Related Experiment Video
Updated: Feb 3, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Standardized Immunomonitoring: Separating the Signals from the Noise
1Dendritic Cell Immunobiology Unit, Institut Pasteur, Paris, France; INSERM U1223, Paris, France.
Insights
New protein assays and standardized immune stimulation methods can improve clinical immune response monitoring. These advances are key for adopting precision medicine strategies in healthcare.
Area of Science:
- Clinical immunology
- Biomarker discovery
- Precision medicine
Background:
- Classical immunoassays are standard for disease diagnosis and monitoring.
- Advanced phenotyping technologies can broaden immune response monitoring.
- Clinical translation of novel immune monitoring tools faces challenges.
Purpose of the Study:
- To discuss strategies for advancing the clinical adoption of immune-based biomarkers.
- To highlight methods for improving the reliability and utility of immune response monitoring in clinical settings.
Main Methods:
- Focus on protein-based assays with digital readouts to minimize nonspecific signals.
- Describe standardized immune stimulation approaches to reveal disease-specific signatures.
- Emphasize integrating immune response phenotypes for clinical applications.
Main Results:
- Digital readouts in protein assays reduce limitations of classical methods.
- Standardized stimulation enhances detection of disease-specific immune responses.
- Improved immune phenotyping is crucial for precision medicine.
Conclusions:
- Protein-based digital assays and standardized immune stimulation are promising for clinical use.
- These strategies can overcome current limitations in immune monitoring.
- Integrating immune phenotypes is essential for advancing precision medicine.
Abstract:
Classical immunoassays are routinely performed in the clinic for disease diagnosis and monitoring. Recent advances in phenotyping technologies offer huge potential in expanding the breadth of immune response monitoring. Challenges remain, however, in translating many of these tools to routine clinical practice. This Opinion focuses on two strategies that may advance the clinical adoption of immune-based biomarkers: protein-based assays employing digital readouts can reduce nonspecific signals that limit more classical assays; and approaches that stimulate immune responses in more standardized ways can help to reveal disease-specific immune response signatures by elevating the signal above the background. The integration of such immune response phenotypes is a critical step for the increased implementation of precision medicine-based strategies.
Related Concept Videos
Standard Enthalpy of Formation
Standard Electrode Potentials
Measurement: Standard Units
Calculating Standard Free Energy Changes
Standard Solutions
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

